re: ........theory...... I like the last sentence of the 1st paragraph.
Dr Ella Toombs - Regulatory Advisory Consultant
Dr Toombs was a dermatology specialist with the US Food and Drug Administrations (FDA) for 13 years. Her primary focus will be to assist EpiTan prepare its Investigational New Drug (IND) application for Melanotan.
This application will be submitted in mid-2004 to the FDA Division of Dermatologic Drugs, a division in which Dr Toombs spent ten years. During this time Dr Toombs reviewed numerous IND proposals for novel drug applications and traditional dermatologics.
Dr Toombs is the Washington DC representative on the advisory board of the Americal Academy of Dermatology and a member of the National Medical Association and American Association of Pharmaceutical Physicians.
She is currently a consultant in private practice specialising in aesthetic dermatology.
re: ........theory...... I like the last sentence of the 1st...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.44 |
Change
0.000(0.00%) |
Mkt cap ! $773.2M | |||
| Open | High | Low | Value | Volume |
| $15.62 | $15.63 | $15.38 | $104.2K | 6.721K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 817 | $15.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.44 | 149 | 6 |
View Market Depth
| Last trade - 11.15am 17/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |